Key Figures
| Figures |
2009 | 2010 | 2011 | 2012 | ||
|---|---|---|---|---|---|---|
| 31.12. | 31.12. | 31.12. | 1.1.-31.3. | 1.1.-31.3. | Variance | |
| |
||||||
| Hannover Re Group | ||||||
| Results | ||||||
| Gross written premium (1) | 10,274.8 | 11,428.7 | 12,096.1 | 3,143.1 | 3,510.6 | +11.7% |
| Net premium earned | 9,307.2 | 10,047.0 | 10,751.5 | 2,490.7 | 2,816.2 | +13.1% |
| Net underwriting result | (100.4) | (185.1) | (535.8) | (382.7) | 0.3 | - |
| Net investment income | 1,120.4 | 1,258.9 | 1,384.0 | 392.0 | 440.6 | +12.4% |
| Operating profit (EBIT) (2) | 1,142.5 | 1,177.9 | 841.4 | 47.4 | 393.2 | +730.3% |
| Group net income | 733.7 | 748.9 | 606.0 | 52.3 | 261.3 | +399.7% |
| +/- 31.12. | ||||||
| Policyholders' surplus (3) | 5,621.6 | 6,987.0 | 7,338.2 | 6,670.6 | 7,705.3 | +5.0% |
| Equity attributable to shareholders of Hannover Re | 3,714.4 | 4,509.0 | 4,970.6 | 4,348.0 | 5,360.4 | +7.8% |
| Non-controlling interests | 542.1 | 608.9 | 636.0 | 590.4 | 612.0 | -3.8% |
| Hybrid capital | 1,365.1 | 1,869.1 | 1,731.6 | 1,732.2 | 1,732.9 | +0.1% |
| Investments (excl. funds withheld by ceding companies) |
22,507.0 | 25,411.1 | 28,341.2 | 24,823.5 | 28,986.7 | +2.3% |
| Total assets | 40,837.6 | 46,725.3 | 49,867.0 | 46,221.8 | 51,120.9 | +2.5% |
| Ratios | ||||||
| Retention | 92.6% | 90.1% | 91.2% | 89.3% | 91.0% | +1.8%p |
| Return on investments (excl. funds withheld by ceding companies) | 4.0% | 3.9% | 3.9% | 5.0% | 5.0% | -0.1%p |
| EBIT margin (4) | 12.3% | 11.7% | 7.8% | 1.9% | 14.0% | +12.1%p |
| Return on equity |
22.4% | 18.2% | 12.8% | 4.7% | 20.2% | +15.5%p |
| Share key figures (8) | ||||||
| Earnings per share |
6.08 | 6.21 | 5.02 | 0.43 | 2.17 | |
| Book value per share |
30.80 | 37.39 | 41.22 | 36.05 | 44.45 | |
| Share price at the end of the period/year end |
32.71 | 40.135 | 38.325 | 38.525 | 44.54 | |
| Price-to-book ratio (11) | 1.06 | 1.07 | 0.93 | 1.07 | 1.00 | |
| Price-earnings ratio |
5.38 | 6.46 | 7.63 | 8.43 | 7.58 | |
| Share performance |
+45.4% | +22.7% | -4.5% | -4.0% | +16.2 | |
| Market capitalisation at the end of the period/year end (14) | 3,944.7 | 4,840.2 | 4,621.9 | 4,646.0 | 5,371.4 | |
| Non-life reinsurance | ||||||
| Gross written premium (1) | 5,746.6 | 6,339.3 | 6,825.5 | 1,924.3 | 2,116.6 | +10.0% |
| Net premium earned | 5,229.5 | 5,393.9 | 5,960.8 | 1,376.3 | 1,554.7 | +13.0% |
| Net underwriting result | 143.5 | 82.4 | (268.7) | (330.9) | 46.8 | - |
| Operating profit (EBIT) (2) | 731.4 | 879.6 | 599.3 | (24.5) | 263.2 | - |
| Group net income | 472.6 | 581.0 | 455.6 | 17.3 | 173.2 | +903.3% |
| Retention | 94.1% | 88.9% | 91.3% | 87.8% | 91.2% | +3.4%p |
| Major losses as percentage of net premium earned (6) | 4.6% | 12.3% | 16.5% | 41.6% | 3.9% | -37.7%p |
| Combined ratio (7) | 96.6% | 98.2% | 104.3% | 123.8% | 96.8% | -27.0%p |
| EBIT margin (4) | 14.0% | 16.3% | 10.1% | (1.8%) | 16.9% | +18.7%p |
| Life and health reinsurance | ||||||
| Gross written premium (1) | 4,529.3 | 5,090.1 | 5,270.1 | 1,219.4 | 1,394.0 | +14.3% |
| Net premium earned | 4,078.7 | 4,653.9 | 4,788.9 | 1,114.5 | 1,261.5 | +13.2% |
| Operating profit (EBIT) (2) | 374.7 | 284.4 | 217.6 | 58.4 | 122.2 | +109.1% |
| Group net income | 298.1 | 219.6 | 182.3 | 41.5 | 100.1 | +141.2% |
| Retention | 90.7% | 91.7% | 91.0% | 91.5% | 90.8% | -0.7%p |
| EBIT margin (4) | 9.2% | 6.1% | 4.5% | 5.2% | 9.7% | +4.4%p |
Further financial information: